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Abstract 
Background: Due to the predisposing conditions in patients with cystic fibrosis 
(CF) caused by defective mucociliary clearance facilitating colonization and 
invasion with Candida species has dramatically increased. Traditional methods for 
identifying problems are imminent and time-consuming. Therefore, molecular 
techniques utilizing amplification of target DNA provide quick and precise 
methods for the diagnosis and identification of Candida species. Therefore, the 
aim of the current study was to identify the most medically common isolated 
Candida species from the air way of CF patients by PCR-RFLP and amplification 
of HWP1 gene. 
Materials and Methods: A total of 42 CF patients presenting symptoms who 
referred to pediatric respiratory diseases research center were screened for the 
presence of Candida spp. The isolates initially were phenotypically identified and 
confirmed by molecular approaches based on restriction fragment length 
polymorphism (PCR-RFLP) for the discrimination of C. albicans of non-albicans 
and the amplification of HWP1 gene for the discrimination of C. albicans from C. 
dubliniensis and C. africana was conducted. 
Results: The results show that C. albicans was the most frequently isolated 
species (83.8%) followed by non-albicans included C. parapsilosis (7.1%), C. 
glabrata (3.2%), and C. tropicalis (3.2%). The restriction patterns of each 
Candida species were perfectly specific. Since MspI could not discriminate 
between the three morphological related species, C. albicans, C. dubliniensis and 
C. africana, we used PCR amplification of HWP1 gene, which (7.1%) species 
from C. albicans identified as C. dubliniensis, however C. africana strains were 
not found. 
Discussion: The present study found that C. albicans as predominant species 
wereisolated from the CF patients. It could be concluded that molecular diagnostic 
methods are reliable and would be useful for the identification of medically 
important Candida species in clinical samples. Therefore, considerable attention 
has been paid to the prevention and treatment of microbial growth, which has 
resulted in the improvement of patient management. 
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Introduction 
Cystic fibrosis (CF) is an autosomal recessive 
disorder that causes abnormalities of ion transport of 
epithelial cells and presents as a multisystem disease 
(1, 2). The airways of CF patients are colonized by 
pathogenic micro-organisms and most patients 
experience recurrent acute respiratory episodes (3). 
Understanding the microbial flora of the CF 
respiratory tract is of considerable importance, as 
patient morbidity and death are primarily caused by 
chronic respiratory infections (4). Most studies of CF 
pathogens have focused on four major bacterial 
species. Also, both yeasts and filamentous fungi have 
been identified as microbial pathogens in CF (5, 6, 7). 
One particular fungal genus isolated at high 
frequencies from sputum culture is Candida and 
some studies have shown that airway colonization 
with Candida may cause symptoms in CF patients 
(8). The frequent use of broad-spectrum antibiotics, 
impairs salivary secretion, the use of corticosteroid 
treatments, and CF-related diabetes predisposes CF 
patients to colonization of the upper and lower 
airways with Candida spp. (9-11). It is still 
controversial whether Candida species are transient 
or persistent colonizers of the airways or more simply 
an oral carriage (12). Due to the predisposing 
conditions of Candida colonization in these patients, 
identification and discrimination of ethological 
agents for early treatment, and preventing the 
invasion is highly recommended. Therefore, due to 
the high degree of phenotypic similarity between 
Candida species, identification of the problems are 
imminent. Conventional approaches for identification 
down to the species level are based on morphological 
and physiological criteria, need several days or weeks 
to be concluded, and are frequently unspecific. 
However, today molecular tools are well established. 
Sequencing of the partial ribosomal operon is 
relatively expensive. Therefore, alternative molecular 
assay with high specificity, reproducibility and 
sensitivity are necessary. Thus, the objective of this 
study was to identify the most common Candida 
species isolated from CF patients using both the 
polymerase chain reaction-restriction fragment length 
polymorphism (PCR-RFLP) assay and amplification 
of HWP1 gene. 
 
Materials and Methods 
Yeast isolates 
From February 2012 through April, Forty-two CF 
patients were surveyed for colonization of their air 
way by Candida species. Sputum samples were 
collected from these patients during routine clinical 
visits or during an admission to the respiratory 
disease research center in Masih Daneshvari Hospital 
(Tehran, Iran). The specimens were inoculated onto 
Sabouraud dextrose agar containing antibiotics, and 
incubated at 37°C for 2 days. Yeast growth was semi 
quantitatively noted as none, light (<10 colonies), 
moderate (10–50 colonies), or heavy (>50 colonies). 
Primarily, these strains were identified by phenotypic 
methods such as colony color on CHROMagar 
Candida medium (CHROMagar Company, Paris, 
France), germ-tube tests in serum at 37 ºC for 2–3 h, 
microscopic morphology on corn-meal agar (DIFCO 
laboratories, Detroit, Mich., USA) with 1% tween 80. 
One colony on each identification strain was sub-
cultured for molecular identification. 
 
DNA Extraction 
Genomic DNA was extracted, using the method of 
glass bead disruption (13). Briefly, 300 μL of lysis 
buffer (10 mM Tris, 1 mM EDTA (pH 8), 1% SDS, 
100 mM NaCl, 2% triton X-100), 300 μL of phenol-
chloroform (1:1) solution and equal to 300 μL of 0.5 
mm diameter glass beads, were added to yeast. After 
5 min of vigorous shaking which followed by 5 min 
centrifugation at 10000 rpm, the supernatant was 
isolated and transferred to a new tube and equal 
volume of chloroform was added, mixed gently, 
centrifuged and its supernatant was transferred to a 
new tube. For alcohol precipitation, 0.1 mL volume 
sodium acetate (pH 5.2) and 2.5 mL volume of cold 
absolute ethanol were added and the mixture was 
gently shaken and centrifuged at 10000 rpm for 10 
min at 4°C. After washing with 70% ethanol, the 
pellets resuspended in 100 μL TE buffer (10 mM 
Tris, 1 mM EDTA) and were stored at -20°C prior to 
use. 
 
RCR- RFLP analysis 
The PCR-RFLP method was performed as previously 
described. Briefly, PCR amplification of ITS1-5.8S-
ITS2 rDNA regions was achieved using the universal 
primers ITS1 (5-TCC GTA GGT GAA CCT GCG 
G-3 and ITS4 (5-TCC TCC GCT TAT TGA TAT 
GC-3) (MWG-Biotech AG, Germany). To amplify 
ITS domains, PCR amplification was performed in a 
final volume of 50 µl. Each reaction consists of 2 µl 
template DNA, 0.5 µl of each primer at 25 pmol, 1.25 
µl of dNTP (BIORON GmbH, Germany) at 5 mM, 
0.5U Taq DNA polymerase (Roche Diagnostics 
GmbH, Mannheim, Germany) and 5 µl 10× PCR 
buffer. The amplification parameters consist of 35 
cycles of denaturation at 94°C for 1 min, annealing at 
56°C for 1 min, extension at 72°C for 1 min. In the 
first cycle, the denaturation step was 94°C for 5 min 
and in the final cycle the final extension step was 
72°C for 7 min. Subsequently, PCR products were 
digested in a final reaction volume of 15μl containing 
3 μl water, 1.5μl buffer, 1U of restriction enzyme 
MspI and 10 μl PCR product at 37˚C for 2h.
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 Amplified and digested products were visualized by 
1.5% and 2%  agarose gel electrophoresis in TBE 
buffer (0.09 M Tris, 0.09 M boric acid and 2 mM 
EDTA, pH 8.3), respectively, and stained with 
ethidium bromide (0.5 µg/ml) and photographed. The 
size of DNA fragments was determined directly with 
comparison of molecular size marker and distinct 
banding patterns which was demonstrated in similar 
studies. 
 
PCR-HWP1 for Discrimination of C. albicans 
complex 
Definitive species identification and discrimination of 
all members of the C. albicans species complex (C. 
albicans, C. dubliniensis, C. africana, and C. 
stellatoidea) was performed via the amplification of 
the hyphal wall protein 1 (HWP1) gene as described 
by Romeo and Criseo (14). PCR amplification of 
HWP1 gene was achieved using the forward, 5′-
GCTACCACTTCAGAATCATCATC-3′and reverse, 
5′-GCACCTTCAGTCGTAGAGACG-3′ primer 
pairs. The method is also identified because it 
produces 3 different DNA fragments: approximately 
700 bp for C. africana, 941 bp for C. albicans, and 
569 for C. dubliniensis. 
 
Sequence analysis of ITSr DNA region 
Randomly for confirmation, the identity of the 
species sequenced. Sequence analysis of ITS1 and 
ITS2 regions of the rDNA was performed according 
to Lott et al. [17] through company MWG (Eurofins 
MWG Operon, Ebersberg, Germany) with a Big Dye 
Terminator Cycle Sequencing Kit on an ABI 3730 
Genetic Analyzer (Pleasanton, CA, USA). The 
sequences generated were compared to the available 
data in the NCBI database using the Basic Local 
Alignment Search Tool (BLASTn) 
(http://www.ncbi.nlm.nih.gov/). 
 
Results 
After the digestion with MspI enzyme, the results 
were evaluated based on the sizes of PCR products 
for Candida species, i.e. 297, 238 bp for C. albicans; 
557, 314 bp for C. glabrata; 340, 184 bp for C. 
tropicalis; 261, 249 for C. krusei; 520 bp for C. 
parapsilosis. The ITS regions of all tested isolates 
were successfully amplified. The digestion of ITS 
region of Candida species by MspI enzyme created 
bands for C. albicans, C. glabrata, and C. tropicalis. 
For C. parapsilosis, the size of the PCR and digestion 
product was similar (Figure 1). 
 
Figure 1 demonstrates the patterns of ITS-RFLP for 
Candida strains after digestion with MspI. As shown, 
the fragment lengths were exactly the same as the 
estimated sizes in the computational sequence 
analysis. Results show that C. albicans was the most 
frequently isolated species (83.8%) followed by non-
albicans including C. parapsilosis (7.1%), C. 
glabrata (3.2%), and C. tropicalis (3.2%).  
The restriction patterns of each Candida species were 
perfectly specific. Since MspI is not able to 
discriminate between three morphological similar 
species, C. albicans, C. dubliniensis and C. africana, 
we used PCR amplification of HWP1 gene, which 
(7.1%) species from C. albicans identified as C. 
dubliniensis; however C. africana strains were not 
found (Figure 2). 
 
 
Fig1. Patterns of PCR products of Candida isolates after digestion 
by the restriction enzyme MspI. Lanes of 1, 3 represent C. 
albicans; 2, C. parapsilosis; and 4, C. glabrata. Lane M is 100 bp 
ladder molecular size marker. 
 
 
Fig 2. Species-specific amplification of the HWP1gene; Lane 1, 2 
and 4 for C. albicans; Lane 3 and 5, for C. dubliniensis 
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Discussion  
Although recently molecular approaches have been 
developed for the identification and discrimination of 
Candida species, novel techniques for the diagnosis 
based on species level have been established in 
routine laboratories. These tools are crucially 
required for the identification of Candida species to 
reduce morbidity and mortality, and for the treatment 
of patients suffering from candidiasis. Given the 
recent evidence that Candida species would be of 
clinical impact on respiratory function in patient with 
CF (15-17), we investigated to know the prevalence 
of Candida species in sputum samples from CF 
patients using the PCR-RFLP method. 
Consistent with the results of previous studies, the 
overall Candida colonization rate was high in our 
study group (8, 11, 12). A striking result of this study 
is that C. albicans as predominant species were 
isolated from CF patients. Prior studies showed that 
C. albicans was the most frequent species in the CF 
patients (18, 19), although, it remains controversial as 
to whether Candida species are transient or persistent 
colonizers of the respiratory tract in CF (8). However, 
the regular assessment of airway colonization is one 
of the basic guidelines in clinical follow-up of these 
patients. Newer airway Candida species for example 
C. dubliniensis also emerged over the last decade 
(20). This new organism was subsequently described 
in the non-HIV population particularly in individuals 
receiving high antibiotic burdens such as CF patients 
(21-23). The present study found that 7.1% of 
Candida species were isolated from CF patients 
identified as C. dubliniensis. In this study, molecular 
analysis performed by amplification of the HWP1 
gene showed that 7.1% of Candida species isolated 
from CF patients identified as C. dubliniensis. 
Molecular diagnostic provide a rapid and frequently 
highly discriminatory means of identifying infectious 
organisms (24). The use of a PCR-RFLP method to 
identifying infectious organisms is a rapid, almost 
inexpensive and completely valid method for the 
identification of Candida spp. This method is useful 
for clinical and epidemiological investigation both 
mucocutaneous and systemic forms (25). In this 
study, we apply a PCR-RFLP method to identify the 
medically important Candida species and similar to 
other studies, the same results were obtained via 
PCR-RFLP methods in detecting different Candida 
spp. (24, 26, 27). In conclusion, in this study we 
found that CF patients are often colonized with 
Candida species and C. albicans as predominant 
species isolated from this patients. It can be 
concluded that molecular diagnostic methods are 
reliable and would be useful for the identification of 
medically important Candida species in clinical 
samples. 
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